Warren Buffett is Selling These 3 Stocks in 2022
Royalty Pharma plc (NASDAQ:RPRX) is a New York-based firm that buys biopharmaceutical royalties and funds innovations in the biopharmaceutical industry in the United States.
Repros Therapeutics Inc. (RPRX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
5 Best Dividend Stocks According to Andreas Halvorsen's Viking Global
In this article, we discuss the 5 best dividend stocks according to Andreas Halvorsen's Viking Global.
Warren Buffett Is Selling These 10 Stocks
Value investors have once again come into the spotlight as inflation batters growth stocks.
10 Best Healthcare Stocks To Buy In 2022
The post-COVID world has highlighted several existing and emerging healthcare trends, such as shifting consumer preferences, the collaboration of life sciences and healthcare, new digital health technologies...
Royalty Pharma Plc (RPRX) Fell Out Of Favor With Hedge Funds
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Harvard University Stock Portfolio: Top 5 Picks
In this article, we discuss the top 5 picks in Harvard University's Stock portfolio.
Hedge Funds Are Crazy About Royalty Pharma Plc (RPRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Steve Cohen's Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen's Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is RPRX A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
